Indication: Diagnosed mild to moderate melasma on both sides of the face.
Research
Cosmetic Laser Dermatology works hard to remain at the forefront of laser and cosmetic surgery research while maintaining the highest industry standards. Our studies are conducted by board-certified dermatologists in pursuit of advancing the field of cosmetic and laser dermatology while optimizing the appearance of your skin in the process. We’ve been a part of over 280 studies since 1974!
Eligible trial participants may receive free treatment and even additional compensation for their particular trial provided they participate fully in all necessary observation periods, reporting sessions with the doctors, etc. for the duration of the study.
Please call 858-657-1004 or email [email protected] to see if you are eligible for one of our studies.
Learn what it's like to be enrolled in our studies
Participating in a clinical trial is not unlike going to a doctor’s appointment. You will meet with the coordinator and investigator for the trial to determine whether you are eligible to participate in the trial, which may require lab work or additional evaluations. Once enrolled, participants attend a treatment visit to receive the medication or treatment, which may take 30 minutes to two hours depending on the medication, injectable product, laser or device that is being tested. In order to monitor the results, participants may be asked to return for a follow-up appointment weekly, monthly, or every three months, depending on the treatment.
In many cases, clinical trial sponsors often provide participants with compensation for their time. To participate in additional studies, participants must wait at least 30 days after concluding a trial before they can be considered eligible.
If you are interested in participating in one of our many exciting clinical research studies, please provide us with as much information as possible and a member of our research team will contact you shortly.
UPCOMING: Melasma Potenza Study
Topical hydrating serum after laser treatment to face
Indication: Moderate to severe fine lines/wrinkles face. Good general health with no skin conditions or tattoos to the area. Male and females with pre-planned laser treatment and willing to apply serum post-treatment.
Vitiligo study (spray on skin cells)
Indication: Focal, segmental or generalized stable vitiligo with no new depigmented areas or that have expanded in the preceding 12 months with no other dermatologic conditions (other than vitiligo). Excludes lips, eyelids, plantar surface of feet or surface of the hands.
UPCOMING: Abdominal Subcutaneous fat (injections)
Indication: Abdominal fat moderate to severe (BMI between 18.5 and 30 Kg/m2) with a stable body weight for the last 3 months and with a stable lifestyle.
PSORIASIS MICRONEEDLE PATCH
Indication: Observational study to examine RNA biomarkers of psoriasis subjects through the application of a Microneedle patch
Study Specifics: For male or female patients 18+ who have been diagnosed with Psoriasis with the affected area greater than 2 cm in diameter. Patients must be treated with IL-17 (Cosentyx) and IL-23 (Skyrizi/Tremfya/Iilumya) therapy once enrolled.
Duration: 12 weeks
Redness to the face study (topical treatment)
Indication: Mild to moderate facial redness or blotchy redness
Duration: 8 weeks
Pruritus (itching)
Indication: Diagnosed with chronic pruritus (CP) of unknown origin for at least 6 months. CP must affect at least 2 of the following body areas: legs, arms or trunk
Actinic Keratosis
Indication: Mild to moderate actinic keratosis on both hands or arms
Study Specifics:
This trial will compare the efficacy of Ameluz activated by Red Light versus Levulan activated by Blue Light for the treatment of Actinic Keratosis on the Upper Extremities
Duration:
Approximately 1 year (6 visits)
Acne
Indication: Moderate to severe acne
Study Specifics: Evaluating the safety and efficacy of Ameluz and BF-RhodoLED in the treatment of moderate to severe acne
Duration: 6 months
